Ophtascan by OncoTech – the vanguard of cancer and diabetes early detection. Our AI-powered system is the first of its kind, clinically tested and validated to provide on-demand screening with precision and ease.
In the fight against cancer, early detection is pivotal. It's not just about creating advanced technology; it's about delivering hope and saving lives. Ophtascan represents a leap forward in medical innovation, making comprehensive screening more accessible and efficient than ever before.
Our commitment goes beyond innovation. In a world where cancer remains a leading cause of death, we strive to bridge the gap in healthcare disparities. Ophtascan is designed to be a cost-effective solution, bringing life-saving diagnostics to communities worldwide, no matter their socioeconomic status.
With Ophtascan, we're not just imagining a world where cancer is conquered—we're actively expanding across the world. Stay updated on our progress, learn about our technology, and join us on this transformative journey towards a cancer free future.
For more information, visit Ophtascan.ai.
#Ophtascan #CancerEarlyDetection #AIRevolution #OncoTech #InnovateForLife #CancerFreeWorld
Company Details
- Address
- 1 Charterhouse Mews, London,england Ec1m 6bb,united Kingdom
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.ophtascan.ai/
- HQ
- London, England
- Competitors
- inField Solutions Inc., Oncotech, Virtace Inc., Tata Group.
Ophtascan Questions
Ophtascan's website is https://www.ophtascan.ai/
Ophtascan's LinkedIn profile is https://uk.linkedin.com/company/ophtascan
Ophtascan's industry is
Medical Equipment Manufacturing
Ophtascan's categories are Medical Equipment Manufacturing
